Dandelion root cancer claim goes viral

Dandelion root is the latest “natural cure” getting passed around like settled fact. The hook is simple and powerful — a common weed, a huge percentage, a brutal disease. But the claim going viral now is not new research, and it is not evidence that dandelion root treats colon cancer in people. What actually exists is a 2016 lab study, plus some animal work, and a very big gap between those results and real-world cancer care. ### Where did the viral number come from? The number comes from a paper published in *Oncotarget* on August 22, 2016 by researchers at the University of Windsor and the University of Ottawa. In that study, an aqueous dandelion root extract killed more than 95% of colon cancer cells within 48 hours in lab experiments. The same paper also said oral dosing slowed growth of human colon tumor xenografts in mice by more than 90%. (oncotarget.com) ### So is the post totally made up? Not exactly — but it is stripped of the part that matters most. “Killed cancer cells” here means cancer cells in vitro, basically in dishes, under controlled lab conditions. That is a real result. But social posts usually flatten that into “dandelion root kills colon cancer,” which is a much bigger claim than the study supports. ### Why is lab success not the same as a treatment? (oncotarget.com) Because bodies are not petri dishes. A substance can look impressive when it is poured directly onto isolated cancer cells and then fail once digestion, metabolism, dosing limits, immune responses, and side effects enter the picture. Mouse studies help a little, but they still do not tell you whether a treatment is safe or effective in humans with actual cancers, other illnesses, and standard drug regimens. That is the whole reason clinical trials exist. ### What do cancer centers say about dandelion? Memorial Sloan Kettering’s herb database says dandelion root extract has shown anticancer effects in melanoma, leukemia, pancreatic, and colorectal cancer cell lines. But that wording is careful for a reason — it is describing preclinical evidence, not a validated therapy. The center also flags possible side effects and interactions, which is another thing viral posts tend to skip. (oncotarget.com) ### Were there human trials? Human trials were approved years ago. The University of Windsor announced in February 2015 that researchers had clearance to test dandelion root extract in patients with terminal cancer. But later reporting said recruitment was difficult, and the public record still does not show this becoming an established cancer treatment. That silence matters. If there were convincing human results, they would be much easier to point to than a decade-old mouse-and-cell paper. (mskcc.org) ### Why do oncologists worry about posts like this? Because some patients take them literally. CBC and PolitiFact both documented doctors getting calls from people who thought they should stop medication and use dandelion root instead. That is the real harm pattern here — not curiosity about plants, but the leap from “interesting preclinical signal” to “ditch treatment.” (uwindsor.ca) ### What’s the clean takeaway? Dandelion root extract has shown intriguing anticancer activity in lab and mouse studies. That part is real. But the viral claim turns early-stage research into a human cure story, and that leap is not supported. If you see “90%” or “95%” in a post, read the missing words after it — “of cancer cells, in a lab.” ### Bottom line This is a classic science-gets-lost-in-translation story. (cbc.ca) A 2016 preclinical paper keeps getting recycled as if it were fresh proof of a cure. It is not. Promising? Sure. Proven in people? No. (oncotarget.com)